Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.73 |
| ▸ | PPARG | P37231 | 5/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.64 |
| ▸ | PPARD | Q03181 | 4/20 | 0.64 |
| ▸ | PPARA | Q07869 | 4/20 | 0.64 |
| ▸ | F7 | P08709 | 4/20 | 0.64 |
| ▸ | F3 | P13726 | 4/20 | 0.64 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.64 |
| ▸ | FABP4 | P15090 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3679461 | 1.00 | TRPV1 (0.73) | TRPV1PPARGALDH1A1PPARDPPARA | |
| SCHEMBL3682356 | 1.00 | TRPV1 (0.73) | TRPV1PPARGALDH1A1PPARDPPARA | |
| SCHEMBL30105511 | 1.00 | TRPV1 (0.73) | TRPV1PPARGALDH1A1PPARDPPARA | |
| SCHEMBL3679463 | 1.00 | TRPV1 (0.73) | TRPV1PPARGALDH1A1PPARDPPARA | |
| SCHEMBL19572670 | 1.00 | TRPV1 (0.73) | TRPV1PPARGALDH1A1PPARDPPARA | |
| SCHEMBL3682340 | 1.00 | TRPV1 (0.73) | TRPV1PPARGALDH1A1PPARDPPARA | |
| SCHEMBL3682951 | 1.00 | TRPV1 (0.73) | TRPV1PPARGALDH1A1PPARDPPARA | |
| SCHEMBL29567605 | 1.00 | TRPV1 (0.73) | TRPV1PPARGALDH1A1PPARDPPARA | |
| SCHEMBL3682342 | 1.00 | TRPV1 (0.73) | TRPV1PPARGALDH1A1PPARDPPARA | |
| SCHEMBL1160534 | 1.00 | TRPV1 (0.73) | TRPV1PPARGALDH1A1PPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1810961-B1 | Method of co-producing olefins and diesters or diacids by homometathesis of unsaturated fatty bodies in non-aqueous ionic liquids | INST FRANCAIS DU PETROLE (FR) | 2010-12-29 | — | — | EP | disclosed |
| US-7754904-B2 | Process for co-producing olefins and diesters or diacids by homomethathesis of unsaturated fats in non-aqueous ionic liquids | INSTITUT FRANCAIS DU PETROLE (FR) | 2010-07-13 | — | — | US | disclosed |
| US-20070179302-A1 | PROCESS FOR CO-PRODUCING OLEFINS AND DIESTERS OR DIACIDS BY HOMOMETHATHESIS OF UNSATURATED FATS IN NON-AQUEOUS IONIC LIQUIDS | INSTITUT FRANCAIS DU PETROLE (FR) | 2007-08-02 | — | — | US | disclosed |
| EP-1810961-A1 | Method of co-producing olefins and diesters or diacids by homometathesis of unsaturated fatty bodies in non-aqueous ionic liquids | Institut Français du Pétrole (FR) | 2007-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070179302-A1 | PROCESS FOR CO-PRODUCING OLEFINS AND DIESTERS OR DIACIDS BY HOMOMETHATHESIS OF UNSATURATED FATS IN NON-AQUEOUS IONIC LIQUIDS | FADS2, SCD, FADS1 | TRPV1 3405/4885PPARG 599/4885ALDH1A1 1459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.